Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001999480-24-000022
Filing Date
2024-05-14
Accepted
2024-05-14 16:32:55
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alto-20240331.htm   iXBRL 10-Q 1374852
2 EX-31.1 exhibit311-302certceo1.htm EX-31.1 12903
3 EX-31.2 exhibit312-302certcfo1.htm EX-31.2 12944
4 EX-32.1 exhibit321-906certceo1.htm EX-32.1 8232
5 EX-32.2 exhibit322-906certcfo1.htm EX-32.2 8243
11 alto-20240331_g1.jpg GRAPHIC 847070
  Complete submission text file 0001999480-24-000022.txt   7864670

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alto-20240331.xsd EX-101.SCH 50124
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alto-20240331_cal.xml EX-101.CAL 49951
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alto-20240331_def.xml EX-101.DEF 247254
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alto-20240331_lab.xml EX-101.LAB 532958
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alto-20240331_pre.xml EX-101.PRE 366264
69 EXTRACTED XBRL INSTANCE DOCUMENT alto-20240331_htm.xml XML 494941
Mailing Address 369 SOUTH SAN ANTONIO RD. LOS ALTOS CA 94022
Business Address 369 SOUTH SAN ANTONIO RD. LOS ALTOS CA 94022 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41944 | Film No.: 24945002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)